Melatonin for Kids
The Sleep Gummy That Became a Poison-Control Story
Evidence grade 3 of 5, Mixed. Read how the Atlas grades evidence.
Grade 3 (moderate), and population-specific. For sleep-onset problems in children with autism spectrum disorder, and to a lesser degree ADHD, the evidence is the strongest in this entry: the 2020 American Academy of Neurology practice guideline (Williams Buckley et al., endorsed by the AAP and AASM) recommends melatonin when behavioral strategies alone are insufficient, supported by multiple double-blind RCTs and a meta-estimate of roughly a 33 minute reduction in sleep-onset latency versus placebo. The Esposito 2019 systematic review of RCTs reaches the same population-specific conclusion. For typically developing healthy children, the benefit is uncertain and the evidence is weak (grade 1 to 2 for that group): melatonin is not established as a nightly fix and behavioral sleep measures are first-line. The AAP and the AASM 2022 health advisory both stress that melatonin is a hormone, not a vitamin or sleeping pill, that OTC supplement dosing and content are unreliable, and that use should be short-term and clinician-guided. The grade reflects the specific, guideline-backed autism/ADHD claim, not a blanket endorsement for all children.
- FDA
- Sold as a supplement; a hormone, not FDA-regulated as a drug; doses unverified
- WADA
- Not prohibited
Reference only. Not medical advice.
What can go wrong
The core risks are accidental over-ingestion and dose uncertainty. Gummies look and taste like candy, and CDC surveillance links that appeal to a 530% rise in pediatric poison-control cases from 2012 to 2021, with 4,097 hospitalizations, 287 ICU admissions, and 2 infant deaths (ages 3 months and 13 months, both at home). Because melatonin is an unregulated supplement, the amount in the product is often not the amount on the label. Reported short-term side effects can include grogginess, headache, and vivid dreams, and because melatonin is a hormone, the AAP notes open questions about effects on growth and development during puberty with routine long-term use. It should be stored secured and out of reach like a medication. Behavioral sleep strategies are first-line, and any ongoing sleep problem in a child, especially in the context of autism or ADHD, warrants evaluation and decisions made together with a qualified pediatric clinician rather than a default reach for a gummy. This entry provides no dosing.
Melatonin belongs in its own entry because it is unlike the rest of the aisle: it is a hormone the body makes, not a nutrient, sold over the counter as candy-like gummies. As children's use spread, the safety signal grew loud. US poison-control data reported by the CDC show pediatric melatonin ingestions rose 530% between 2012 and 2021, from 8,337 to 52,563 cases, becoming a leading reported pediatric ingestion. Because melatonin is sold as a dietary supplement, products are loosely regulated, and a 2023 JAMA analysis found most tested gummies were mislabeled, ranging from 74% to 347% of the stated dose, with one product containing no melatonin at all. There is real, clinician-supervised value in specific situations, and multiple randomized trials support short-term use for sleep-onset problems in autism and ADHD, but for ordinary childhood sleep it is not a nightly fix and not a substitute for routines, consistent timing, and limits on evening screens.
Melatonin is a hormone sold as a candy-like gummy, and as use soared, pediatric ingestions rose more than 500%, with the actual dose in the bottle often not matching the label.
What people take it for
These are the reasons people give for taking it. They are not effects it has been shown to have.
Safety in detail
Melatonin is a hormone, not a vitamin, and is the reason this entry carries a foregrounded poison-control warning. CDC surveillance ties candy-like gummies to a 530% rise in pediatric ingestions from 2012 to 2021, including thousands of hospitalizations and, rarely, deaths in infants, and to about 11,000 ED visits from 2019 to 2022. Because US melatonin is an OTC supplement, the amount in the bottle is often not the amount on the label, ranging in one JAMA analysis from 74% to 347% of the stated dose. Store it secured and out of reach like any medicine, keep the Poison Control number 1-800-222-1222 accessible, and treat behavioral sleep strategies as first-line. Any ongoing sleep problem, especially with autism or ADHD, warrants evaluation with a qualified pediatric clinician. In most of the world outside the US, melatonin is a prescription-only medicine, not a candy-aisle gummy. This entry provides no dosing.
What people get wrong
Often saidMelatonin is a harmless natural sleep vitamin for kids.
ActuallyMelatonin is a hormone, not a vitamin, and as a supplement it is loosely regulated. A 2023 JAMA analysis found 88% of tested gummies mislabeled, from 74% to 347% of the stated dose, with one containing none. CDC-reported pediatric ingestions rose 530% from 2012 to 2021, including 4,097 hospitalizations and 2 infant deaths, so harmless is the wrong frame.
Often saidIf a child has trouble sleeping, melatonin every night is the fix.
ActuallyBoth the AAP and the American Academy of Sleep Medicine describe melatonin as not a sleeping pill and advise behavioral sleep strategies first, with any use decided together with a pediatrician. It is best framed as occasional, short-term, clinician-guided help, not an indefinite nightly self-treatment.
Often saidThe dose in the bottle is the dose on the label.
ActuallyFor a supplement, that assumption fails often. The 2023 JAMA analysis measured 74% to 347% of the labeled melatonin across 25 gummy products, and the AASM advisory cites content variation reported as roughly -83% to +478% of label, with the widest spread in the chewables children use most.
Often saidMelatonin does not really work for kids, so it is just a placebo.
ActuallyFor typical healthy children the benefit is uncertain, but for sleep-onset problems in autism and ADHD several double-blind RCTs reviewed by Esposito 2019 report shorter sleep-onset latency versus placebo. The evidence is real, population-specific, and belongs under clinician supervision, not a blanket dismissal.
Who profits, and who pushes back
US poison-control data
Pediatric melatonin ingestions rose roughly 530% from 2012 to 2021, becoming a leading reported ingestion, with hospitalizations and two reported toddler deaths over the period.
Sleep medicine clinicians
Melatonin can help in specific, short-term situations and under guidance for some neurodevelopmental conditions, but behavioral sleep strategies are first-line and nightly long-term use in healthy children is not established.
Product-content analyses
Because melatonin is sold as a supplement, actual content frequently does not match the label, sometimes substantially higher, complicating safe dosing for children.
Melatonin-gummy marketing
Sells this. Has a commercial interest in a product sold as this compound, as of July 2026.
Markets candy-like melatonin gummies for routine children's sleep, framing that understates the hormone's nature, dose uncertainty, and the documented rise in accidental ingestions, with a commercial interest in nightly use.
Where the research comes from
Most of the published research on this comes from one place. 530% of it is from Rise in pediatric melatonin ingestions 2012-2021. Findings that no unrelated group has reproduced are weaker than the study count makes them look.
| Place | Share of published research |
|---|---|
| Rise in pediatric melatonin ingestions 2012-2021 | 530% |
Research published from: Global.
How we got here
Melatonin was isolated in 1958 by Yale dermatologist Aaron Lerner, who traced a pineal-gland compound that lightened frog skin and named it from the Greek melas for black. Interest in its role as a circadian and sleep signal grew through the 1970s and 1980s. In the United States the 1994 Dietary Supplement Health and Education Act let melatonin be sold over the counter without drug-level review, a regulatory choice not shared by most other countries, where it remained a prescription medicine. Flavored gummies turned the hormone into a mainstream children's product through the 2010s, and poison-control surveillance, capped by the CDC's 2022 MMWR report, documented the parallel rise in accidental pediatric ingestions that defines its safety story today.
Melatonin was isolated in 1958 by American dermatologist Aaron Lerner at Yale, who was studying skin pigment and traced a pineal-gland substance that lightened frog skin; he named it from the Greek melas (black) and the serotonin it derives from. Long before that chemistry, the pineal gland itself carried meaning across cultures: it drew attention in classical Indian and later yogic traditions associated with the ajna region, and in seventeenth-century Europe Rene Descartes called it the seat of the soul. Scientific interest in melatonin as a sleep and circadian signal grew through the 1970s and 1980s. In the United States it reached consumers only after the 1994 Dietary Supplement Health and Education Act let it be sold without drug-level review. Flavored gummies then turned a hormone into a mainstream children's sleep product through the 2010s, and poison-control surveillance soon documented the parallel rise in accidental ingestions that defines its safety story today.
- 1958Aaron Lerner isolates and names melatonin from pineal extract at Yale
- 1994US DSHEA lets melatonin be sold as a dietary supplement, without drug-level review
- 2010sFlavored gummies turn melatonin into a mainstream children's sleep product
- 2012-2021CDC-reported pediatric poison-control ingestions rise 530% (8,337 to 52,563); 4,097 hospitalizations, 287 ICU, 2 infant deaths
- 2019-2020Largest single-year jump in ingestions (37.9%), coinciding with the pandemic
- 2022AASM issues health advisory (Sep 2022) urging clinician consultation; Lelak MMWR publishes the 530% figure
- 2023JAMA analysis (Cohen) finds 88% of tested melatonin gummies mislabeled, 74-347% of stated dose
- 2024MMWR Notes from the Field: ~10,930 ED visits (2019-2022) for unsupervised pediatric melatonin ingestion; gummies most common form
At a glance
- It is
- A hormone, not a vitamin
- Poison-control rise (2012-2021)
- +530% pediatric
- Reported deaths in that surge
- 2 (toddlers)
- Label accuracy
- Often inaccurate (supplement, unregulated)
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Melatonin for Kids. A short entry is not a safe entry.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
Sources
Pediatric melatonin ingestions reported to US poison centers rose 530%, from 8,337 in 2012 to 52,563 in 2021; 4,097 hospitalizations, 287 ICU admissions, 5 children needed mechanical ventilation, and 2 infants died.
Unsupervised pediatric melatonin ingestions accounted for roughly 11,000 US emergency department visits from 2019 to 2022, most in children under 6 who accessed the product themselves.
Of 25 melatonin gummy products, 22 (88%) were inaccurately labeled, ranging from 74% to 347% of the declared melatonin; one contained no detectable melatonin but 31.3 mg of CBD; consuming as directed could expose children to 40 to 130 times a physiologic dose.
JAMA, Cohen PA et al., 'Quantity of Melatonin and CBD in Melatonin Gummies Sold in the US'
Melatonin is a hormone, not a sleeping pill; it should be used only after a discussion with a pediatrician and alongside healthy sleep habits, and is not a fix for long-term sleep problems.
American Academy of Pediatrics, HealthyChildren.org, 'Melatonin and Children's Sleep'
The AASM advises that melatonin be used in children only under clinician guidance, warns that as a supplement its actual content is often inaccurate, and cites reported content variation of about -83% to +478% of label, widest in the chewables children use.
For insomnia in children and adolescents with autism, the guideline recommends behavioral strategies first and pharmaceutical-grade melatonin when behavior alone is insufficient; a meta-estimate found a mean reduction in sleep-onset latency of about 33 minutes versus placebo.
A systematic review of randomized clinical trials found melatonin associated with improved sleep-onset latency and sleep duration in children with autism and ADHD, and concluded the benefit is population-specific and best delivered under clinician supervision.
Synthetic melatonin is widely available OTC in the US, with sales rising from $285 million in 2016 to $821 million in 2020, tracking the same period as the surge in pediatric ingestions.
CDC MMWR (PMC full text), Lelak et al., 'Pediatric Melatonin Ingestions, United States, 2012-2021'
In healthy children, sleep-related melatonin use is common but evidence for typically developing children is limited; behavioral measures are first-line and routine long-term hormonal use raises unresolved questions.